With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, ...

A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...

Meanwhile, cities in New Mexico, Minnesota, Kansas, and Utah are leading the pack for cities who are the most open to trying ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...